4//SEC Filing
GOLDSTEIN ALLAN L 4
Accession 0000914190-19-000005
CIK 0000707511other
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 4:41 PM ET
Size
17.9 KB
Accession
0000914190-19-000005
Insider Transaction Report
Form 4
GOLDSTEIN ALLAN L
Director
Transactions
- Conversion
Common Stock
2019-01-06$0.06/sh+208,912$12,535→ 1,940,793 total - Conversion
Convertible Promissory Note (right to buy)
2019-01-06−208,912→ 0 totalExercise: $0.06From: 2014-01-07Exp: 2019-01-06→ Common Stock (208,912 underlying)
Holdings
- 71,942
Stock Option (right to buy)
Exercise: $0.57Exp: 2019-04-10→ Common Stock (71,942 underlying) - 300,000
Stock Option (right to buy)
Exercise: $0.14Exp: 2019-01-24→ Common Stock (300,000 underlying) - 35,000
Stock Option (right to buy)
Exercise: $0.16Exp: 2019-04-03→ Common Stock (35,000 underlying) - 450,000
Stock Option (right to buy)
Exercise: $0.21Exp: 2021-03-25→ Common Stock (450,000 underlying) - 200,000
Stock Option (right to buy)
Exercise: $0.64Exp: 2023-03-16→ Common Stock (200,000 underlying) - 250,000
Stock Option (right to buy)
Exercise: $0.36Exp: 2022-06-30→ Common Stock (250,000 underlying) - 150,000
Stock Option (right to buy)
Exercise: $0.28Exp: 2027-09-01→ Common Stock (150,000 underlying) - 250,000
Stock Option (right to buy)
Exercise: $0.21Exp: 2028-07-17→ Common Stock (250,000 underlying)
Footnotes (5)
- [F1]The Convertible Promissory Note in the principal amount of $10,000 accrued $2,534.72 in interest and both principal and interest were converted into 208,912 shares of common stock at a conversion price of $0.06 per share.
- [F2]100% vested.
- [F3]50,000 shares vest on each of 3/16/16, 3/16/17, 3/16/18 and 3/16/19.
- [F4]37,500 shares vest on each of 9/1/17, 9/1/18, 9/1/19 and 9/1/20.
- [F5]62,500 shares vest on each of 7/17/18, 7/17/19, 7/17/20 and 7/17/21.
Documents
Issuer
REGENERX BIOPHARMACEUTICALS INC
CIK 0000707511
Entity typeother
Related Parties
1- filerCIK 0000905390
Filing Metadata
- Form type
- 4
- Filed
- Jan 7, 7:00 PM ET
- Accepted
- Jan 8, 4:41 PM ET
- Size
- 17.9 KB